# CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

> **NCT03810196** · NA · RECRUITING · sponsor: **Children's Hospital of Philadelphia** · enrollment: 50 (estimated)

## Conditions studied

- Acute Leukemia
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Acute Lymphoblastic Leukemia
- Mixed Lineage Leukemia
- Lymphoblastic Lymphoma
- Burkitt Lymphoma
- Juvenile Myelomonocytic Leukemia

## Interventions

- **DEVICE:** CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback

## Key facts

- **NCT ID:** NCT03810196
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-01
- **Primary completion:** 2027-02
- **Final completion:** 2028-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03810196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03810196, "CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03810196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*